GlassScriptPhysician profile
Roderick N Hargrove
NPI 1417914896
$3,451.52
in general payments reported to CMS, 2019-2025
20 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $24.35 · 2021: $359 · 2022: $501 · 2023: $431 · 2024: $741 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,249.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.18 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $570.57 | 2019-2024 | Catalys System |
| Alcon Vision LLC | $533.06 | 2019-2025 | Clareon, Ngenuity, Unity |
| Horizon Therapeutics Plc | $454.69 | 2021-2023 | Tepezza |
| Amgen INC. | $292.85 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $182.12 | 2020-2024 | Cequa |
| Bausch & Lomb Americas INC. | $146.38 | 2025 | Miebo, Xiidra |
| Allergan, INC. | $119.48 | 2019-2022 | |
| Eyepoint US, INC. | $90.15 | 2019 | |
| Rayner Intraocular Lenses Limited | $67.43 | 2023-2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Lensar, INC. | $51.59 | 2025 | Lensar Laser System |
| Notal Vision, INC. | $34.28 | 2025 | Foresee Home |
| Tarsus Pharmaceuticals, INC. | $31.99 | 2024 | Xdemvy |
| Harrow Eye, LLC | $28.64 | 2025 | Vevye |
| Ani Pharmaceuticals, INC. | $24.54 | 2024 | Purified Cortrophin Gel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $24.39 | 2021 | |
| Merz Pharmaceuticals, LLC | $23.80 | 2025 | Xeomin |
| Aerie Pharmaceuticals, INC. | $22.19 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2023 | Veracity Surgical |
| Thea Pharma INC. | $14.31 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Hargrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.